An ISO 9001:2008 & GMP certified company  | info@arlakbiotech.com  |  +91-9803023099, 7696263636  |  1800-121-6263 (Toll Free) 

ZEFAX-CV DRY SYRUP


Categories: , .
Description

COMPOSITION: – CEFIXIME 50 MG + POTASSIUM CLAVULANATE ACID 31.25MG

PACKING: – 30 ML

M.R.P: – 109

A third-generation cephalosporin antibiotic which is a semi-synthetic in nature. Cefixime has a broad spectrum against gram-positive and gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis.

Clavulanic is derived from Beta-lactamase inhibitor which is produced by bacteria of Streptococcus genus. Clavulanic acid is an irreversible inhibitor of intracellular and extracellular β-lactamases, demonstrating concentration-dependent and competitive inhibition.

ZEFAX-CV DRY SYRUP (CEFIXIME 50 MG + POTASSIUM CLAVULANATE ACID 31.25MG) is active for certain bacteria’s. Its main function is to inhibit beta-lactamase. The antibiotics with beta-lactam such as penicillins and cephalosporins function on inhibition of cell wall synthesis of the bacteria`s which interrupts in the replication of bacteria.

ZEFAX-CV DRY SYRUP has a combination of cefixime and clavulanic acid (ß-lactamase inhibitor) that treats the infections caused by beta-lactam resistance pathogens.

INDICATIONS: –

  • Uncomplicated urinary tract infections
  • Otitis Media
  • Pharyngitis and Tonsillitis
  • Acute bronchitis and acute exacerbations of chronic bronchitis
  • Uncomplicated gonorrhea (cervical/urethral)
Contact Us
close slider